Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level.

British journal of haematology - 1 Apr 1997

Brugiatelli M, Claisse J F, Lenormand B, Morabito F, Callea V, Malloum K, Chevret S, Binet J L, Dighiero G, Travade P

Abstract excerpt

This retrospective study aimed to evaluate the long-term prognostic impact of phenotypic remission in B-cell chronic lymphocytic leukaemia (CLL) patients who have achieved clinical, haematological and bone-marrow complete remission (CR) after conventional chemotherapy. The clinical and phenotypic data of 77 CLL patients in CR with a median follow-up from CR achievement of 54 months (range 5-127) were analysed. 32...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Combined Chemotherapy Protocols

Share to Disease-Free Survival

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Phenotype

Share to Remission Induction

Share to Treatment Outcome

Source

Identifiers

PMID: 9136949
DOI: 10.1046/j.1365-2141.1997.9922637.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level.PMID 9136949Read ↗

Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia?Semantic proximity Read ↗

[Commentary on development of the prognostic factors concept in chronic lymphocytic leukaemia: the route from prognostic factors to therapy response predictors].Semantic proximity Read ↗

[New perspectives in the evolution of prognosis and treatment of chronic lymphocytic leukaemia].Semantic proximity Read ↗

Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia.Semantic proximity Read ↗

Defining the prognosis of early stage chronic lymphocytic leukaemia patients.Semantic proximity Read ↗

Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 casesSemantic proximity Read ↗

Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.Semantic proximity Read ↗

[Chronic lymphocytic leukemia: high time for a risk-adapted approach].Semantic proximity Read ↗

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.Semantic proximity Read ↗

A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B‐cell chronic lymphocytic leukemiaSemantic proximity Read ↗

Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features.Semantic proximity Read ↗

Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.